Inventor

RITTER GERD

US82 patents

⚠️ This page may combine multiple inventors who share the name “RITTER GERD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RITTER GERD

AGENUS INC

Anti-GITR antibodies and methods of use thereof

Anti-OX40 antibodies

Anti-GITR antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-PD-1 antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Nucleic acids encoding anti-OX40 antibodies

Anti-GITR antibodies and methods of use thereof

Anti-CTLA-4 antibodies and methods of use thereof

Anti-PD-1 antibodies and methods of use thereof

Vectors comprising nucleic acids encoding anti-OX40 antibodies

Anti-GITR antibodies and methods of use thereof

Antibodies and methods of use thereof

Methods of administering anti-OX40 antibodies

Antibodies and methods of use thereof

Anti-OX40 antibodies

Anti-GITR antibodies and methods of use thereof

LUDWIG INST CANCER RES

A33 antigen specific immunoglobulin products and uses thereof

Specific binding proteins and uses thereof

Process for producing GM2 specific antibodies

Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein

Method for treating neoplasia using humanized antibodies which bind to antigen A33

Methods of treating colon cancer utilizing tumor-specific antibodies

Isolated nucleic acid which encodes protein which binds to A33 antibody

Method for treating cancer using A33 specific antibodies and chemotherapeutic agents

Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products

Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof

Specific binding proteins and uses thereof

Process for producing GM1 specific antibodies

RITTER GERD

Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy

Logging and evaluating manual interactions by users to support optimizing and streamlining business processes

Specific binding proteins and uses thereof

Temporary highlighting of selected fields

SEUBERT MICHAEL

Consistent set of interfaces derived from a business object model

Consistent set of interfaces derived from a business object model

Consistent set of interfaces derived from a business object model

SEITZ FILTER WERKE

Filter material in the form of flexible leaves or sheets and a method of producing such material

Cellulose matrix filter material

Filter material formed by fibride particles

SAP SE

Replication of user interface events

Data synchronization error resolution based on UI manipulation actions

Data synchronization error resolution

STUMPF DIRK

Field transformations for user interface data elements

User interface model driven data access control

SAP AG

Modeled authorization check implemented with UI framework

BRUNSWIG FRANK

Managing business objects